Enveric Biosciences Files 8-K on Shareholder Nominations
Ticker: ENVB · Form: 8-K · Filed: Mar 28, 2024 · CIK: 890821
| Field | Detail |
|---|---|
| Company | Enveric Biosciences, Inc. (ENVB) |
| Form Type | 8-K |
| Filed Date | Mar 28, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-action
TL;DR
Enveric Biosciences filed an 8-K about shareholder nominations - potential board shakeup incoming.
AI Summary
Enveric Biosciences, Inc. filed an 8-K on March 28, 2024, to report shareholder nominations pursuant to Exchange Act Rule 14a-11. The filing details the company's corporate structure and its principal executive offices located at 4851 Tamiami Trail N, Suite 200, Naples, FL 34103.
Why It Matters
This filing indicates potential changes or activism within Enveric Biosciences, as it relates to shareholder nominations for the board.
Risk Assessment
Risk Level: medium — Filings related to shareholder nominations can signal internal disputes or activist investor involvement, which may lead to significant corporate changes.
Key Numbers
- 001-38286 — SEC File Number (Identifies the company's filing history with the SEC.)
- 95-4484725 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Enveric Biosciences, Inc. (company) — Registrant
- 4851 Tamiami Trail N, Suite 200, Naples, FL 34103 (location) — Principal executive offices
- Exchange Act Rule 14a-11 (regulation) — Subject of the filing
FAQ
What is the specific purpose of the shareholder nominations mentioned in the 8-K?
The 8-K states the filing is regarding shareholder nominations pursuant to Exchange Act Rule 14a-11, but does not detail the specific purpose or individuals nominated within this excerpt.
When was the report filed and what is the date of the earliest event reported?
The report was filed on March 28, 2024, and the date of the earliest event reported is March 27, 2024.
What is Enveric Biosciences, Inc.'s principal executive office address?
The principal executive offices are located at 4851 Tamiami Trail N, Suite 200, Naples, FL 34103.
What is the company's state of incorporation and fiscal year end?
The company is incorporated in Delaware and its fiscal year ends on December 31.
Has Enveric Biosciences, Inc. had previous names?
Yes, the company was formerly known as AMERI Holdings, Inc. (name change on 20150527) and SPATIALIZER AUDIO LABORATORIES INC (name change on 19950323).
Filing Stats: 574 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2024-03-28 16:55:14
Key Financial Figures
- $0.01 — ch registered Common stock, par value $0.01 per share ENVB The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 35KB
- 0001493152-24-011774.txt ( ) — 205KB
- envb-20240327.xsd (EX-101.SCH) — 3KB
- envb-20240327_lab.xml (EX-101.LAB) — 33KB
- envb-20240327_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: March 28 , 2024 ENVERIC BIOSCIENCES, INC. By: /s/ Joseph Tucker Joseph Tucker, Ph.D. Chief Executive Officer